仑胜医药关注

更多
  • 股票期权
  • 绩效奖金
  • 午餐补助
  • 定期体检
  • 弹性工作
  • 管理规范
  • 五险一金

公司介绍

仑胜医药(Sinovant Sciences)是一家位于上海的创新生物制药公司,在北京和香港设有分公司;由包括“海归”华人科学家和医生在内的团队创立,并得到了中国投资机构中信产业基金和全球创新医疗集团Roivant Sciences的投资支持。凭借中信产业基金对大中华地区和亚洲医疗市场的战略洞察力,以及Roivan Sciences的全球业务发展能力和药物开发技术平台,仑胜医药其独特的定位和优势,能够将全球前沿医疗创新引入中国,并把中国具有显著临床优势的医疗创新推向世界。

仑胜医药目前有13种多样化的在研药品,其中5种候选药物已经进入临床三期或更后期阶段,这些在研药品涵盖超过8个治疗领域包括:肿瘤学,抗感染,泌尿疾病,代谢疾病,肺病,肠胃病,皮肤病和罕见病。

作为一家年轻富有活力的公司,仑胜聚集了一批有理想有抱负有深度行业经验的海内外华人科学家和医师精英团队、各专业杰出人才,以及立志成为中国医药行业领军团队的年轻人。

如欲了解更多信息,请您访问公司网站:www.sinovant.com 。

Sinovant Sciences is an innovative biopharmaceutical company based in Shanghai, China with offices in Beijing and Hong Kong. Sinovant was founded by Chinese scientists and physicians, including Chinese “Returnees”, and is backed by CITIC Private Equity, one of China’s leading investment funds, and Roivant Sciences, a leading global family of innovative healthcare companies. Leveraging CITIC Private Equity’s strategic insights into healthcare markets in Greater China and Asia and Roivant’s global business development network and drug development capabilities, Sinovant is uniquely positioned to bring cutting-edge global medical innovation to China, and transformative Chinese medical innovation to the world.

Sinovant has a diverse pipeline of 13 investigational products in development, among which 5 drug candidates are in phase III or beyond. Our products span over 8 therapeutic areas including oncology, infectious disease, urology, metabolic disease, pulmonary disease, gastroenterology, dermatology and rare diseases.

As a young and energetic company, we have gathered a group of ambitious and seasoned Chinese scientists and physicians at home and abroad, outstanding talents in various fields, and young people who aspire to be the leading team in China's pharmaceutical industry.

For more information, please visit: www.sinovant.com

点击展开更多详情

招聘职位 ( 共12 个 )